Arvinas Holding Company LLC (ARVN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

395 WINCHESTER AVE NEW HAVEN, CT 06511

Arvinas, Inc. operates as a bio-pharmaceutical company. The Company develops protein degradation therapeutics for cancers and other diseases. Arvinas serves health care industry worldwide.

View SEC Filings from ARVN instead.

View recent insider trading info

Funds Holding ARVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARVN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

12.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CANAAN IX L.P.

CANAAN PARTNERS IX LLC

  • 10% Owner
7,925,919 2020-01-14 0

HOUSTON JOHN G PRESIDENT AND CEO

  • Officer
  • Director
797,844 2019-12-17 3

SMALDONE ALSUP LAURIE

  • Director
0 2019-11-20 2

CASSIDY SEAN A CHIEF FINANCIAL OFFICER

  • Officer
159,115 2019-11-19 4

TAYLOR IAN CHIEF SCIENTIFIC OFFICER

  • Officer
55,496 2019-11-13 5

RATCLIFFE LIAM

  • Director
680,000 2019-11-12 2

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • 10% Owner
5,422,312 2019-10-16 0

MORRISON BRIGGS CHIEF EXECUTIVE OFFICER

31,400 2019-10-10 1

PARMAR KUSH

  • Director
1,775 2019-09-24 3

SHANNON TIMOTHY M

  • Director
0 2019-09-24 2

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
7,406,307 2019-09-17 0

5AM VENTURES III, L.P.

5AM PARTNERS III, LLC

5AM CO-INVESTORS III, L.P.

DIEKMAN JOHN D

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
3,316,059 2019-09-16 4

NORWALK LESLIE V

  • Director
0 2019-09-10 2

PECK RONALD CHIEF MEDICAL OFFICER

  • Officer
0 2019-07-29 2

LOVEN JAKOB

  • Director
0 2019-05-23 1

KENNEDY EDWARD MOORE JR.

  • Director
0 2019-05-23 1

MARGUS BRADLEY ALBERT

  • Director
0 2019-05-23 1

CREW ANDREW SEE REMARKS

  • Officer
0 2019-03-01 1

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUP
No longer subject to file 2018-10-01 0

ELM STREET VENTURES L P

ELM STREET VENTURE ASSOCIATES, LLC

BETTIGOLE ROBERT A.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-10-01 0

CONNECTICUT INNOVATIONS INC

  • 10% Owner
0 2018-09-26 0

CRAIG M. CREWS FAMILY 2013 TRUST

  • 10% Owner
560,000 2018-09-26 0

NEW LEAF VENTURES III, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

  • 10% Owner
0 2018-09-26 0

CREWS CRAIG MARTIN

  • 10% Owner
0 2018-09-26 0

CREWS FAMILY 2018 TRUST

  • 10% Owner
538,461 2018-09-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2019-12-17 M 12,500 $16.00 a 797,844 797,844.00 direct

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2019-12-17 M 12,500 d 94,400 797,844.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments